Related Experiment Video
Updated: Jun 21, 2026

Dynamic Contrast Enhanced Magnetic Resonance Imaging of an Orthotopic Pancreatic Cancer Mouse Model
Published on: April 18, 2015
Pancreatic adenocarcinoma: dynamic 64-slice helical CT with perfusion imaging
Jin Xu1, Zonghui Liang, Sijie Hao
1Department of General Surgery, Pancreatic Disease Institution, Huashan Hospital, Fudan University, Shanghai 200040, China.
Background:
Perfusion CT is able to outline blood perfusion changes in a tissue. Thus, in lesions of the tissues of the pancreas, this offers to increase the accuracy of CT diagnosis. In this study, our aim was to explore the perfusion characteristics of normal pancreas and pancreatic adenocarcinoma.
Methods:
Dynamic 64-slice helical CT was conducted in 36 patients with non-pancreatic disease and in 40 patients with histopathologically proven pancreatic adenocarcinoma. Perfusion parameters including blood flow (BF), blood volume (BV), and permeability surface area product (PS) were recorded.
Results:
There was no significant difference noted between the distribution of BF, BV, and PS values in different regions of the pancreas, namely the head, neck, body, and tail (P > 0.05). The BF, BV, and PS of normal pancreas were recorded as 135.24 +/- 48.36 ml min(-1) 100 g(-1), 200.55 +/- 54.96 ml 100 g(-1), and 49.75 +/- 24.27 ml min(-1) 100 g(-1), respectively. BF, BV, and PS values of the tumor tissue of pancreatic adenocarcinoma decreased significantly compared to normal pancreas (P < 0.05).
Conclusions:
Normal pancreas appears homogenous on perfusion CT. A significant decrease of BF, BV, and PS was observed in pancreatic adenocarcinoma. Dynamic 64-slice helical CT with perfusion imaging should be considered a potential modality to increase the accuracy of CT diagnosis for pancreatic adenocarcinoma.
More Related Videos
09:18Multianimal Magnetic Resonance Imaging for Tumor Measurements in Pancreatic Cancer Mouse Models
Published on: February 3, 2026
09:49Dual-phase Cone-beam Computed Tomography to See, Reach, and Treat Hepatocellular Carcinoma during Drug-eluting Beads Transarterial Chemo-embolization
Published on: December 2, 2013